Preview

Russian Journal of Transplantology and Artificial Organs

Advanced search

Kidney transplant program in Irkutsk Region

https://doi.org/10.15825/1995-1191-2025-2-46-53

Abstract

Introduction. Kidney transplantation (KT) is often considered the best option for renal replacement therapy (RRT), significantly improving patient outcomes. Post-transplant, life expectancy doubles, and mortality decreases more than 4-fold compared to other RRT modalities. This article presents KT outcomes in Irkutsk Region from 2018 to 2023. All procedures were performed at a single center – the Irkutsk Regional Clinical Hospital.

Objective: to analyze the immediate and long-term outcomes of KT in Irkutsk Region.

Material and methods. A retrospective analysis was conducted on the treatment outcomes of 125 patients with kidney failure (KF). Among them, 74 were men with a median age of 42 (35–49) years, and 51 were women with a median age of 46 (37–55) years. The median transplant waitlist time was 15.5 (range: 6–32) months. The leading cause of KF was chronic glomerulonephritis, observed in 60 patients (48%). There were no HLA matches in 36 patients (28.8%), while 38 patients (30.4%) had one match. Arterial anastomosis was primarily performed end-to-end with the external iliac artery in 121 cases (96.8%), while in 3 cases (2.4%), the internal iliac artery was used due to external iliac artery spasm. Cold ischemia time was 222 minutes (range: 162–360), and warm ischemia time was 39 minutes (range: 30–46).

Results. Length of hospital stay was 16 (range: 13–25) bed days. Primary renal function was achieved in 95 patients (77%), while 25 patients (20%) experienced delayed graft function. Blood tacrolimus reached target levels by postoperative days 9–12. Creatinine level at discharge was 120 μmol/L (range: 97–165). Surgical complications occurred in 24 patients (19.2%), while urinary tract infections were observed in 36 patients (28.8%), with 17 cases (13.6%) presenting clinical symptoms. Immunosuppressive therapy was initiated in 124 patients (99.2%) using a standard triple-drug regimen (calcineurin inhibitors, mycophenolates, and glucocorticoids). One patient (0.8%) succumbed to complications from COVID-19. One-year graft survival was 94.1%.

Conclusion. The immediate outcomes align with national averages. There is a consistent upward trend in the number of kidney transplants performed. Further development of the regional transplant program will enhance access to this high-tech medical service, meeting the needs of the local population.

About the Authors

A. V. Novozhilov
Irkutsk Regional Clinical Hospital; Irkutsk State Medical University
Russian Federation

Irkutsk



S. E. Grigoriev
Irkutsk Regional Clinical Hospital; Irkutsk State Medical University
Russian Federation

Sergey V. Grigoriev

1, Krasnogo Vosstaniya, Irkutsk, 664003



O. Yu. Yakovleva
Irkutsk Regional Clinical Hospital
Russian Federation

Irkutsk



S. A. Yezhikeev
Irkutsk Regional Clinical Hospital
Russian Federation

Irkutsk



References

1. Gautier SV. Clinical transplantology in the Russian Federation: from innovative phenomenology to accessible medical care. Russian Journal of Transplantology and Artificial Organs. 2022; 24 (4): 5–6. [In Russ, English abstract].

2. Karakulina EV, Khomyakov SM, Aleksandrova ОА, Lysikov IV, Shedenko SV, Gautier SV. Ways of improving the legal regulation of human organ and tissue transplantation in the Russian Federation. Russian Journal of Transplantology and Artificial Organs. 2022; 24 (2): 108–118. [In Russ, English abstract]. doi: 10.15825/1995-1191-2022-2-108-118.

3. Lakman IA, Khalikova AA, Korzhenevskiy AA. The evaluation of effect of various outcomes of kidney transplantation surgery on economic costs under treatment of kidneys chronic disease. Zdravookhranenie Rossiiskoi Federatsii (Health Care of the Russian Federation Russian journal). 2018; 62 (2): 60–67. [In Russ, English abstract]. doi: 10.18821/0044-197X-2018-62-2-60-67.

4. Smirnova VV, Shmarina NV, Dmitriev IV, Balkarov AG, Zagorodnikova NV, Vinogradov VE, Minina MG. Early and long-term outcomes of deceased-donor kidney transplant in recipients 70 years of age and older. Russian Journal of Transplantology and Artificial Organs. 2024; 26 (3): 111–116. [In Russ, English abstract]. doi: 10.15825/1995-1191-2024-3-111-116.

5. Khubutiya MSh, Pinchuk AV, Shmarina NV, Dmitriev IV, Vinogradov VE, Kazantsev AI, Balkarov AG. Patient and kidney graft survival rates after first and second kidney transplantation. Transplantologiya (The Russian Journal of Transplantation). 2021; 13 (2): 130–140. [In Russ, English abstract]. doi: 10.23873/2074-0506-2021-13-2-130-140.

6. Aleksandrova VO, Dmitriev IV, Borovkova NV, Balkarov AG, Mushta NA, Shma¬rina NV et al. Diagnostic value of anti-HLA antibody monitoring in the diagnosis of immunological complications following kidney transplantation. Russian Journal of Transplantology and Artificial Organs. 2024; 26 (3): 91–98. [In Russ, English abstract]. doi: 10.15825/1995-1191-2024-3-91-98.

7. Pirov BS, Odinaev OM, Izatshoev AA, Samadov AH, Nazarov PH. Results of kidneys transplantation in the regional department of human organs and tissues transplantation. Vestnik poslediplomnogo obrazovaniya v sfere zdravoohraneniya (Bulletin of Postgraduate Education in Healthcare). 2018; 4: 86–91. [In Russ, English abstract].

8. Minina MG, Sevostyanov VM, Tenchurina EA. 30 donors per million population in Moscow. Impact on the effectiveness of transplant care. Russian Journal of Transplantology and Artificial Organs [In Russ]. 2024; 26 (S): 5. doi: 10.15825/1995-1191-2024-S-5.

9. Information on the population number and demographic characteristics of the Irkutsk region [Internet]. The official portal of the Irkutsk region [website]. Cited 2025 Jan 19. Available from: https://irkobl.ru/region/demografy.


Supplementary files

Review

For citations:


Novozhilov A.V., Grigoriev S.E., Yakovleva O.Yu., Yezhikeev S.A. Kidney transplant program in Irkutsk Region. Russian Journal of Transplantology and Artificial Organs. 2025;27(2):46-53. https://doi.org/10.15825/1995-1191-2025-2-46-53

Views: 200


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1995-1191 (Print)